FdaApplication
BLA 761355
Identifiers
- fda_app_no: BLA761355
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2023-08-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EYLEA HD | AFLIBERCEPT | 8MG(0.07ML | Injection |
1 product